Wattle Health Australia ASX:WHA) has finalised the legally binding supply agreement with International Supplies and Distribution Company (ISDC) to supply their conventional cow infant formula for sale in general trade in China.
ISDC has guaranteed a total of over 5 million units of products over a 42- month period resulting in a revenue of around $100 million.
This agreement is an important milestone for Wattle in its China strategy as they expand their product portfolio.
WHA is actively selling baby food in China with a pipeline of products including fresh organic milk, organic senior nutritional products, sports nutrition and other organic powder based products.
Shares in Wattle Health Australia ASX:WHA) closed 0.61 per cent lower to 82 cents.